Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

Share Price is delayed by 15 minutes
Get Live Data
569.80    0.00 (0.00%)
Bid:
0.00
Ask:
610.00
Spread: 39.80 (6.98%)
Market Cap: £3.65b
ENT Live PriceLast checked at - London Stock Exchange

Intraday Entain Share Chart

Director/PDMR Shareholding

6 Mar 2026 14:03

RNS Number : 6951V
Entain PLC
06 March 2026

6 March 2026

Entain plc

("Entain" or "Group" or "Company")

Notification of Transactions by Persons Discharging Managerial ResponsibilityOr Persons Closely Associated

Awards granted under the Entain plc 2017 Long Term Incentive Plan ("LTIP") and under the Annual and Deferred Bonus Plan ("ADBP")

Entain plc (LSE: ENT), the global sports betting and gaming group, announces that the following award over Entain ordinary shares of ?0.01 each ("Shares") was granted to an Executive Director of the Company under the Rules of the LTIP on 6 March 2026 as set out below:

Name

Role

Number of Shares subject to the Award

Michael Snape

CFO

70,391

The LTIP award will normally vest on 6 March 2029, subject to continuous employment.

Entain also announces that the following award over Shares was granted to an Executive Director of the Company under the Rules of the ADBP on 6 March 2026 as set out below:

Name

Role

Number of Shares subject to the Award

Stella David

CEO

193,442

In the Company's remuneration policy, 50% of the Executive Directors' annual bonus is deferred in shares. The above deferred bonus award has therefore been granted in respect of the CEO's annual bonus for the 2025 financial year. This award will normally vest on 6 March 2029, being the third anniversary of the award date (subject to continued employment).

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of English law by virtue of the European Union (Withdrawal) Act 2018.

Enquiries:

Company Secretary

Investor Relations - Entain plc

secretary@entaingroup.com

investors@entaingroup.com

Media - Entain plc

media@entaingroup.com

Sodali & Co

Rob Greening/Russ Lynch/Sam Austrums

Tel: +44 (0) 20 7250 1446

entain@sodali.com

LEI: 213800GNI3K45LQR8L28

About Entain plc

Entain plc (LSE: ENT) is a FTSE100 company and is one of the world's largest sports betting and gaming groups, operating both online and in the retail sector. The Group owns a comprehensive portfolio of established brands; Sports brands include BetCity, bwin, Coral, Crystalbet, Eurobet, Ladbrokes, Neds, Sportingbet, Sports Interaction, STS and SuperSport; Gaming brands include Foxy Bingo, Gala, GiocoDigitale, Ninja Casino, Optibet, Partypoker and PartyCasino. The Group operates the TAB NZ brand as part of a long-term strategic partnership with TAB New Zealand. The Group owns proprietary technology across all its core product verticals and in addition to its B2C operations provides services to a number of third-party customers on a B2B basis.

The Group has a 50/50 joint venture, BetMGM, a leader in sports betting and iGaming in the US. Entain provides the technology and capabilities which power BetMGM as well as exclusive games and products, specially developed at its in-house gaming studios. The Group is tax resident in the UK and is the only global operator to exclusively operate in domestically regulated or regulating markets operating in over 30 territories.

Entain is a leader in ESG, a member of FTSE4Good, the S&P Global Sustainability Yearbook and is AAA rated by MSCI. For more information see the Group's website: www.entaingroup.com

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Michael Snape

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Entain plc

b)

LEI

213800GNI3K45LQR8L28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of Entain plc of ?0.01 each

IM00B5VQMV65

b)

Nature of the transaction

Grant of conditional shares under the Entain plc 2017 Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

70,391

d)

Aggregated information

-

Aggregated volume

-

Price

70,391 ordinary shares of ?0.01 each

Nil consideration

e)

Date of the transaction

06/03/2026

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Stella David

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Entain plc

b)

LEI

213800GNI3K45LQR8L28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of Entain plc of ?0.01 each

IM00B5VQMV65

b)

Nature of the transaction

Grant of conditional shares under the Entain plc Annual and Deferred Bonus Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

193,442

d)

Aggregated information

-

Aggregated volume

-

Price

193,442 ordinary shares of ?0.01 each

Nil consideration

e)

Date of the transaction

06/03/2026

f)

Place of the transaction

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBGGDXCXGDGLL
Date   Source Headline
20th Nov 20257:00 amRNSTR1: Notification of Major Holdings
13th Nov 20257:00 amRNSPricing of €500 million Senior Secured Notes
10th Nov 20258:00 amRNSProposed Refinancing Transaction
6th Nov 20253:10 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:00 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSQ3 Trading Update
14th Oct 202512:00 pmRNSBetMGM Q3 2025 Update and Raised FY25 Guidance
14th Oct 20258:59 amRNSTR1: Notification of Major Holdings
1st Oct 20257:01 amRNSBlock Listing Six Monthly Return
1st Oct 20257:00 amRNSTotal Voting Rights
5th Sep 20252:44 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amRNSTotal Voting Rights
12th Aug 20257:01 amRNSInterim Results
12th Aug 20257:00 amRNSAppointment of Non-Executive Chair
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSSuccessful repricing and extension of Term Loans
29th Jul 20257:00 amRNSBETMGM 2Q/1H 2025 UPDATE & FY25 GUIDANCE INCREASE
3rd Jul 20252:00 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20259:00 amRNS-RNew Zealand Government Establishes Legislative Net
16th Jun 20257:00 amRNSBetMGM - Upgraded FY 2025 Guidance
4th Jun 20259:48 amRNSDirector/PDMR Shareholding
2nd Jun 202510:26 amRNSTotal Voting Rights
15th May 20257:00 amRNSBoard Appointments
6th May 202512:34 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
29th Apr 20257:01 amRNSQ1 Trading Update
29th Apr 20257:00 amRNSAppointment of Chief Executive Officer
28th Apr 202512:00 pmRNSBetMGM Q1 2025 Update
23rd Apr 202511:59 amRNSResult of AGM
4th Apr 202510:20 amRNSTR1: Notification of Major Holdings
3rd Apr 20259:35 amRNSDirector/PDMR Shareholding
1st Apr 20257:01 amRNSBlock Listing Six Monthly Return
1st Apr 20257:00 amRNSTotal Voting Rights
21st Mar 20254:33 pmRNSAnnual Report, AGM and Directorate Change
19th Mar 202510:39 amRNSDirector/PDMR Shareholding
17th Mar 20259:46 amRNSTR1: Notification of Major Holdings
10th Mar 20252:24 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
3rd Mar 20257:00 amRNSTotal Voting Rights
14th Feb 20251:52 pmRNSDirectorate and Board Committee Changes
14th Feb 202510:49 amRNSTR1: Notification of Major Holdings
11th Feb 20257:00 amRNSDirectorate Change
4th Feb 202512:00 pmRNSBETMGM FY 2024 Update
31st Jan 20257:00 amRNSTR1: Notification of Major Holdings
13th Jan 20257:00 amRNSReiteration of FY24 EBITDA guidance
6th Jan 20259:06 amRNSDirector/PDMR Shareholding
3rd Jan 202512:04 pmRNSBlock Listing Six Monthly Return
2nd Jan 20257:50 amRNSTotal Voting Rights
17th Dec 20247:00 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.